Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial

American Medical Association, JAMA Oncology, 2(2), p. 209

Journal article published in 2015 by William N. William, Vassiliki Papadimitrakopoulou, J. Jack Lee, J. Jack Lee, Li Mao, Ezra E. W. Cohen, Heather Y. Lin, Ann M. Gillenwater, Jack W. Martin, Mark W. Lingen, Jay O. Boyle, Dong M. Shin, Nadarajah Vigneswaran, Nancy Shinn, John V. Heymach and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by